The IL-23/IL-17 cascade is thought to play a major role in psoriasis, particularly because clinical outcomes of psoriasis are dramatically improved by therapies targeting IL-17 and IL-23 [18,19,20]. This evidence concerns the gene IL17A and psoriasis.